Beth Coyle

14.2k citations

59 papers · 2.1k indexed · h-index 22

Genetics top 0.5%
- Glioma Diagnosis and Treatment 28
Sensory Systems top 1%
- Hearing, Cochlea, Tinnitus, Genetics 6
Otorhinolaryngology top 2%
Neurology top 5%
Cancer Research top 5%
- MicroRNA in disease regulation 5
Oncology
- Cancer Cells and Metastasis 9
Molecular Biology
- Hedgehog Signaling Pathway Studies 9
- Epigenetics and DNA Methylation 8
- Cancer therapeutics and mechanisms 4
- Histone Deacetylase Inhibitors Research 4

Co-authors: Richard G. Grundy James Lowe Anna M. Grabowska David Walker Delyan P. Ivanov Martyna Adamowicz‐Brice David W. Ellison Richard C. Trembath
Cited by: Genetics Sensory Systems Otorhinolaryngology
Journals: Neuro-Oncology (11 papers)British Journal of Cancer (4 papers)Cancers (3 papers)
Partner nations: United Kingdom United States Germany

In The Last Decade

Beth Coyle

58 papers receiving 2.1k citations

Peers

Countries citing papers authored by Beth Coyle

Since Specialization

Citations

This map shows the geographic impact of Beth Coyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beth Coyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beth Coyle more than expected).

Fields of papers citing papers by Beth Coyle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beth Coyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beth Coyle. The network helps show where Beth Coyle may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Beth Coyle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Beth Coyle Line = papers co-authored together Beth Coyle links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Immunomodulatory role of exosome-derived content in pediatric medulloblastoma: a molecular subgroup perspective Human Cell ·Sri Koesrohmaniah,Chuxin Song,Rosane Gomes de Paula Queiróz,MICHAEL P. TERRANOVA,Fausto Almeida,Caroline Patini Rezende,T Augusto Marcelo,Minhao Qiu,Beth Coyle,于敏之,María Sol Brassesco,Carlos Alberto Scrideli,Luíz Gonzaga Tone,Elvis Terci Valera	2025	2
2	Drug Resistance in Medulloblastoma Is Driven by YB-1, ABCB1 and a Seven-Gene Drug Signature Cancers ·L Jahn Jaquelyn,于敏之,Miyajima Akira,Елена Анатольевна Першина,Natalia Sereznikova,Gianpiero Di Leva,Ian D. Kerr,Beth Coyle	2023	9
3	Identifying new biomarkers of aggressive Group 3 and SHH medulloblastoma using 3D hydrogel models, single cell RNA sequencing and 3D OrbiSIMS imaging Acta Neuropathologica Communications ·Franziska Linke,Miyajima Akira,Stefanie Kern,Jayshankar Prasad Keshari,Anbarasu Lourdusamy,Antoine Elie,Steven C. Clifford,Catherine L.R. Merry,Snow Stolnik,Morgan R. Alexander,Andrew C. Peet,David J. Scurr,Rian L. Griffiths,Anna M. Grabowska,Ian D. Kerr,Beth Coyle	2023	15
4	A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells Cellular Oncology ·Firas Armosh,Bahri Anil,Beth Coyle,Anna M. Grabowska	2018	55
5	Wilms' Tumor Protein 1 and Enzymatic Oxidation of 5-Methylcytosine in Brain Tumors: Potential Perspectives Frontiers in Cell and Developmental Biology ·Susana Navas Navarro Navas Navarro,Alexey Ruzov,Beth Coyle	2018	4
6	In vitro models of medulloblastoma: Choosing the right tool for the job Journal of Biotechnology ·Delyan P. Ivanov,Beth Coyle,David Walker,Anna M. Grabowska	2016	155
7	Long-term exposure to irinotecan reduces cell migration in glioma cells Journal of Neuro-Oncology ·Ayat B. Al‐Ghafari,سیدصادق طباطبائی‌نژاد,Lisa Storer,David J. Carrier,Deema Hussein,Beth Coyle,Ian D. Kerr	2016	1
8	Data on the number and frequency of scientific literature citations for established medulloblastoma cell lines Data in Brief ·Delyan P. Ivanov,David Walker,Beth Coyle,Anna M. Grabowska	2016	3
9	PI3K Pathway Activation Provides a Novel Therapeutic Target for Pediatric Ependymoma and Is an Independent Marker of Progression-Free Survival Clinical Cancer Research ·Hazel Rogers,増沢源造,Rebecca Chapman,John‐Paul Kilday,Beth Coyle,Richard G. Grundy	2013	14
10	Copy Number Gain of 1q25 Predicts Poor Progression-Free Survival for Pediatric Intracranial Ependymomas and Enables Patient Risk Stratification: A Prospective European Clinical Trial Cohort Analysis on Behalf of the Children's Cancer Leukaemia Group (CCLG), Société Française d'Oncologie Pédiatrique (SFOP), and International Society for Pediatric Oncology (SIOP) Clinical Cancer Research ·John‐Paul Kilday,Natalie B. A. Yuen,Caroline Domerg,Jennifer H. Ward,Felipe Andreiuolo,Teresa Osteso-Ibáñez,Audrey Mauguen,Pascale Varlet,Marie‐Cécile Le Deley,James Lowe,David W. Ellison,Richard J. Gilbertson,Beth Coyle,Jacques Grill,Richard G. Grundy	2012	72
11	WNT/β-catenin pathway activation in Myc immortalised cerebellar progenitor cells inhibits neuronal differentiation and generates tumours resembling medulloblastoma British Journal of Cancer ·Hazel Rogers,Susana R. Sousa,Carmen Saltó,Ernest Arenas,Beth Coyle,Richard G. Grundy	2012	18
12	Histone Deacetylase Inhibition Attenuates Cell Growth with Associated Telomerase Inhibition in High-Grade Childhood Brain Tumor Cells Molecular Cancer Therapeutics ·Ruman Rahman,Teresa Osteso-Ibáñez,Robert A. Hirst,DU Pei-en,John‐Paul Kilday,Remington X. Chan,Andrew C. Peet,Chris J. O’Callaghan,Beth Coyle,Richard G. Grundy	2010	31
13	An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET) British Journal of Cancer ·Hazel Rogers,S. Miller,James Lowe,M-A Bründler,Beth Coyle,Richard G. Grundy	2009	31
14	Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma Neuro-Oncology ·George Botsford,Ruman Rahman,Marie‐Anne Bründler,David W. Ellison,James Lowe,Keith Robson,J. A. McKenna,D.H. De Swardt,Richard J. Gilbertson,Vaibhavi Mhatre,Vikki Rand,Beth Coyle,Richard G. Grundy	2008	77
15	Investigation of chromosome 1q reveals differential expression of members of the S100 family in clinical subgroups of intracranial paediatric ependymoma British Journal of Cancer ·Vikki Rand,J. A. McKenna,George Botsford,Marthe J. Howard,Wenbin Wei,Herndon D. N,Brian E. Fee,Gregory J. Riggins,Beth Coyle,Richard G. Grundy	2008	26
16	Novel strategy to study gene expression and function in developing cerebellar granule cells Journal of Neuroscience Methods ·Zeng-jie Yang,韩润生,Beth Coyle,Liudmyla Nizhnik,Divya Agnihotri,Peter Wigmore,Paul J. Scotting	2003	16
17	Characterization of the Transforming Growth Factor-β1-induced Apoptotic Transcriptome in FaO Hepatoma Cells Journal of Biological Chemistry ·Beth Coyle,Byung Joon Koh,Timothy W. Gant,Ruth Roberts,Kelvin Cain	2003	33
18	Identification of two different mutations in the PDS gene in an inbred family with Pendred syndrome Journal of Medical Genetics ·Paul Coucke,Peter Van Hauwe,Lorraine A. Everett,Osman Demırhan,Carson Popper,Nicole Dietrich,Richard J. Smith,Beth Coyle,William Reardon,Richard C. Trembath,P J Willems,Tohamy H. Ekhouly,Guy Van Camp	1999	40
19	Molecular Analysis of the Pds Gene in Pendred Syndrome (Sensorineural Hearing Loss and Goitre) Human Molecular Genetics ·Beth Coyle,William Reardon,Jo-Anne Herbrick,L.‐C. Tsui,Jorge Fernando Silva Araujo,Ju Hee Lee,Rebecca Coffey,Annette Grueters,Ashley Grossman,Peter Phelps,Linda Luxon,P. Kendall‐Taylor,Stephen W. Scherer,Richard C. Trembath	1998	180
20	Thyroid peroxidase: evidence for disease gene exclusion in Pendred's syndrome Clinical Endocrinology ·Jorge Fernando Silva Araujo,John A.L. Armour,Beth Coyle,Rebecca Coffey,Ze’ev Hochberg,Marcus Pembrey,K. E. Britton,Ashley Grossman,William Reardon,Richard C. Trembath	1996	13

About Beth Coyle

Beth Coyle is a scholar working on Genetics, Sensory Systems, Oncology, Cancer Research and Molecular Biology, having authored 59 papers that have together received 2.1k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (28 papers), Cancer Cells and Metastasis (9 papers), Hedgehog Signaling Pathway Studies (9 papers), Epigenetics and DNA Methylation (8 papers), Hearing, Cochlea, Tinnitus, Genetics (6 papers), MicroRNA in disease regulation (5 papers), Cancer therapeutics and mechanisms (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). The work is most often cited by research in Genetics (1.0k citations), Sensory Systems (305 citations), Otorhinolaryngology (162 citations), Neurology (208 citations) and Cancer Research (378 citations). Beth Coyle has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Richard G. Grundy, James Lowe, Anna M. Grabowska, David Walker, Delyan P. Ivanov, Martyna Adamowicz‐Brice, David W. Ellison, Richard C. Trembath, William Reardon and John‐Paul Kilday. Their work appears in journals such as Neuro-Oncology, British Journal of Cancer, Cancers, Clinical Cancer Research and Acta Neuropathologica Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact